RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock

Recursion Pharmaceuticals, Inc. Class A Common Stock represents ownership in Recursion Pharmaceuticals, a clinical-stage TechBio company focused on industrializing drug discovery through data-driven biology and chemistry. The company uses automation, artificial intelligence, machine learning, and engineering to map biological systems and identify novel therapeutic candidates. Its work centers on building a technology-enabled platform for discovering and advancing medicines across areas such as oncology, rare disease, and other complex conditions. Recursion also operates in a research and development environment that combines wet-lab biology with computational tools to improve the efficiency of early-stage drug discovery. Headquartered in Salt Lake City, Utah, Recursion Pharmaceuticals plays a specialized role in the biotechnology market as a developer of platform-based drug discovery capabilities and clinical-stage therapeutic programs.